Main Page Content


Ankylosing spondylitis (AS) is the most common form of inflammatory arthritis affecting the spine. It typically affects young adults and can be accompanied by major disability and limitation in spinal mobility.

UHN Spondylitis Program seeks to improve the quality of life of AS patients through excellence in patient care, innovative research, and effective education strategies for both patients and medical personnel.

Key Research Areas

The research arm of the program encompasses both clinical and basic science research and includes research nurses, research associates, database managers, graduate students, laboratory technicians, and post-doctoral fellows.

The UHN Spondylitis Program has contributed immensely to the progress of AS research, as well as led several ground-breaking studies in both translational and clinical science. We focus on:

  • Basic science studies using genomics, proteomics, and cellular immunology to define the basic mechanisms underlying AS
  • Clinical studies of prognosis and modification of clinical disease
  • Clinical trials of new biologic agents in AS
  • Translational studies exploring the immunological basis of AS, and the genetic factors which influence susceptibility and disease course

The clinical arm of the program incorporates staff rheumatologists, as well as physiotherapists, nurses, and radiologists. We attract physicians from around the globe who have come to TWH to develop experience and expertise in the management of AS.

The program also provides advanced training​ to graduate students, international students, physicians and allied health professionals who wish to develop expertise in this area.

The Spondylitis Program is the administrative and coordinating hub of the Spondyloarthritis Research Consortium of Canada.

Patient Care

Visit the Ankylosing Spondylitis Clinic.


Learn more about our educational opportunities.​

Rheumatology Program


For more information about our educational opportunities, please contact:

Robert Inman

Nigil Haroon